Новосиби́рский госуда́рственный медици́нский университе́т — высшее учебное заведение, занимающееся подготовкой специалистов с высшим медицинским образованием.

During the past decade, Novosibirsk State Medical University conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 21 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 17 clinical trials were completed. i.e. 283.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novosibirsk State Medical University" #1 sponsor was "Celgene" with 8 trials, followed by "Takeda" with 5 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "Eisai Limited" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novosibirsk State Medical University" #1 collaborator was "Novosibirsk State University" with 2 trials as a collaborator, "Atlant Clinical Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Novosibirsk State Medical University" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (4 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (3 trials) and "Type 2 Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Novosibirsk State Medical University" in a lesser frequency.

Most popular intervention types in "Novosibirsk State Medical University" are "Drug" (32 trials), "Other" (4 trials), "Behavioral" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Diet" (3 trials), "Exercise" (3 trials), "GED-0301" (3 trials) and "Ranolazine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Novosibirsk State Medical University" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Novosibirsk State Medical University". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Novosibirsk State Medical University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Novosibirsk State Medical University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".